Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia
Go back to Pacira Pharmaceuticals Statement on FDA Advisory Committee for EXPAREL® for Use as a Nerve Block to Produce Regional Analgesia| PACIRA (NASDAQ: PCRX) | Delayed: 24.70 +0.59 (2.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.11 | 52 Week High | $80.25 | |||
| Open | $24.36 | 52 Week Low | $30.25 | |||
| Day High | $24.97 | P/E | N/A | |||
| Day Low | $24.20 | EPS | $-2.08 | |||
| Volume | 380,504 | |||||

